Skip to search formSkip to main contentSkip to account menu

CD33 Ag:PrThr:Pt:Tiss:Ord:Immune stain

Known as: CD33 Antigen:Presence or Threshold:Point in time:Tissue, unspecified:Ordinal:Immune stain, CD33 , Ag:PrThr:Pt:Tessuto:Ord:Colorazione immunologica, CD33 Ag:PrThr:Moment:Weefsel en uitstrijkjes:Ordinaal:Immunokleuring 
National Institutes of Health

Related topics

Related topics

6 relations
AntigensBody tissueCD33 antigenImmune stain

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Clinical and Radiographic Response of Extramedullary Leukemia in Patients Treated With Gemtuzumab Ozogamicin.
Extramedullary leukemia (EML) is common in pediatric acute leukemia and can present at diagnosis or relapse. CD33 is detected on… 
2017
2017
Das Mikrobiom im Fokus der Immunonkologen
p ix el lie be / st oc k. ad ob e. co m glied der CIMT Regulatory Research Group, die Gesamtansprechrate in 14 abgeschlossenen… 
2011
2011
Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC).
2588 Background: Pre-clinical data demonstrates that Gem and FP treatment leads to substantial falls in MDSCs in murine cancer… 
2011
2011
Photothermal therapy of acute leukemia cells in the near-infrared region using gold nanorods CD-33 conjugates
In the present work, we demonstrate a potential use of gold nanorods as a contrast agent for selective photothermal therapy of… 
2009
2009
Anti-CD33 antibodies and their use for the treatment of CD33 Immunotargeting at-associated diseases
The invention relates to antibodies against the tumor associated antigen CD33 and their use for Immunotargeting of CD33-positive… 
1999
1999
Einsatz mono- und bispezifischer Antikörper in der Tumortherapie
Nachdem es 1974 Köhler und Milstein [15] erstmals gelungen war, monoklonale Antikörper (MoAk) gezielt und in großen Mengen gegen… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)